Cargando…

Dose-adjusted and dose/kg-adjusted concentrations of mycophenolic acid precursors reflect metabolic ratios of their metabolites in contrast with tacrolimus and cyclosporine

Background and purpose: Therapeutic drug monitoring is a valuable tool supporting immunosuppressive therapy. Significant variation of immunosuppressive drug (ISD) concentrations during their use at similar doses is the basis of dose-normalization strategy. The strategy of dose-adjustment is proposed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hryniewiecka, Ewa, Żegarska, Jolanta, Żochowska, Dorota, Samborowska, Emilia, Jaźwiec, Radosław, Kosieradzki, Maciej, Nazarewski, Sławomir, Dadlez, Michał, Pączek, Leszek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744583/ https://www.ncbi.nlm.nih.gov/pubmed/31395739 http://dx.doi.org/10.1042/BSR20182031

Ejemplares similares

Low Transfer of Tacrolimus and Its Metabolites into Colostrum of Graft Recipient Mothers
por: Kociszewska-Najman, Bozena, et al.
Publicado: (2018)

Organization of Post-Transplant Care and the 5-Year Outcomes of Kidney Transplantation
por: Szymańska, Agnieszka, et al.
Publicado: (2022)

Low Content of Cyclosporine A and Its Metabolites in the Colostrum of Post-Transplant Mothers
por: Kociszewska-Najman, Bożena, et al.
Publicado: (2020)

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
por: Sahman, Majda, et al.
Publicado: (2021)

Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention
por: Hamilton, Betty K., et al.
Publicado: (2023)

Tacrolimus dose adjustment is not necessary in dose to dose conversion from a twice daily to a prolonged release once daily dose form
por: Tiankanon, Kanitha, et al.
Publicado: (2022)

Dose Adjustment Strategy of Cyclosporine A in Renal Transplant Patients: Evaluation of Anthropometric Parameters for Dose Adjustment and C0 vs. C2 Monitoring in Japan, 2001-2010
por: Kokuhu, Takatoshi, et al.
Publicado: (2013)

Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy
por: Mao, Youying, et al.
Publicado: (2018)

Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections Due to Extended-Spectrum Beta-Lactamase (ESBL)-Producing Klebsiella pneumoniae
por: Wilkowski, Piotr, et al.
Publicado: (2023)

Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
por: Kim, Hyeyoung, et al.
Publicado: (2014)

Impact of Blood Pressure on Risk of Graft Failure or Death Among Patients After Kidney Transplantation in a 10-Year Observational Period: A Single-Center Retrospective Analysis
por: Pilecki, Tomasz, et al.
Publicado: (2023)

Nonsteroidal Anti-Inflammatory Drugs and Analgesics Use by Kidney Transplant Recipients
por: Mulka-Gierek, Maria, et al.
Publicado: (2018)

A Novel, Dose-Adjusted Tacrolimus Trough-Concentration Model for Predicting and Estimating Variance After Kidney Transplantation
por: Kim, Janet, et al.
Publicado: (2019)

Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients?
por: Robertsen, Ida, et al.
Publicado: (2019)

Plasma metabolomic profiling reveals factors associated with dose-adjusted trough concentration of tacrolimus in liver transplant recipients
por: Zhu, Huaijun, et al.
Publicado: (2022)

Pharmacokinetics and Dose Recommendations for Cyclosporine and Tacrolimus When Coadministered With ABT‐450, Ombitasvir, and Dasabuvir
por: Badri, P., et al.
Publicado: (2015)

Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen—Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil
por: Traitanon, Opas, et al.
Publicado: (2019)

Comparison of Post-Transplantation Lymphoproliferative Disorder Risk and Prognostic Factors between Kidney and Liver Transplant Recipients
por: Mucha, Krzysztof, et al.
Publicado: (2022)

Trimethylamine N-Oxide, a Gut Microbiota-Derived Metabolite, Is Associated with Cardiovascular Risk in Psoriasis: A Cross-Sectional Pilot Study
por: Sikora, Mariusz, et al.
Publicado: (2021)

Clinical Implications of Intestinal Barrier Damage in Psoriasis
por: Sikora, Mariusz, et al.
Publicado: (2021)

Pharmacokinetic Assessment of Drug‐Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults
por: Groll, Andreas H., et al.
Publicado: (2016)

Differences in CYP3A genotypes of a liver transplant recipient and the donor liver graft and adjustment of tacrolimus dose
por: Berger, Florine A., et al.
Publicado: (2019)

Prediction of Tacrolimus Dose/Weight-Adjusted Trough Concentration in Pediatric Refractory Nephrotic Syndrome: A Machine Learning Approach
por: Mo, Xiaolan, et al.
Publicado: (2022)

Alteration of urinary neutrophil gelatinase–associated lipocalin as a predictor of tacrolimus-induced chronic renal allograft fibrosis in tacrolimus dose adjustments following kidney transplantation
por: Chancharoenthana, Wiwat, et al.
Publicado: (2018)

Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS) with a New Pathogenic Variant in TNFRSF1A Gene in a Family of the Adult Male with Renal AA Amyloidosis—Diagnostic and Therapeutic Challenge for Clinicians
por: Zegarska, Jolanta, et al.
Publicado: (2021)

Association of mycophenolic acid dose with efficacy and safety events in kidney transplant patients receiving tacrolimus: an analysis of the Mycophenolic acid Observational REnal transplant registry
por: Doria, Cataldo, et al.
Publicado: (2012)

An Open-Label Investigation into Drug–Drug Interactions Between Multiple Doses of Daclatasvir and Single-Dose Cyclosporine or Tacrolimus in Healthy Subjects
por: Bifano, Marc, et al.
Publicado: (2015)

Correction: Alteration of urinary neutrophil gelatinase-associated lipocalin as a predictor of tacrolimus-induced chronic renal allograft fibrosis in tacrolimus dose adjustments following kidney transplantation
Publicado: (2019)

Are doses of lamotrigine or levetiracetam adjusted during pregnancy?
por: Richards, Noni, et al.
Publicado: (2017)

No Dose Adjustment for Isavuconazole Based on Age or Sex
por: Desai, Amit V., et al.
Publicado: (2019)

Critical Analysis of Apixaban Dose Adjustment Criteria
por: Vu, Anh, et al.
Publicado: (2021)

Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry
por: Langone, Anthony, et al.
Publicado: (2013)

Transfer of Everolimus into Colostrum of a Kidney Transplant Mother
por: Kociszewska-Najman, Bożena, et al.
Publicado: (2017)

Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches
por: Garcia-Romeu, Albert, et al.
Publicado: (2021)

Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma
por: García-Romero, N., et al.
Publicado: (2020)

How to adjust drug doses in chronic kidney disease
por: Stefani, Maurizio, et al.
Publicado: (2019)

Dose adjustment of antidiabetic medications in chronic kidney disease
por: Snyder, Matthew Salvatore, et al.
Publicado: (2021)

Response to “Critical Analysis of Apixaban Dose Adjustment Criteria”
por: Mandt, Stephen R., et al.
Publicado: (2022)

The role of CYP3A5 polymorphism and dose adjustments following conversion of twice-daily to once-daily tacrolimus in renal transplant recipients
por: Zaltzman, Alina S. R, et al.
Publicado: (2016)

Mycophenolate-mofetil/prednisone/tacrolimus: Infections: case report
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0q9s69gcf8t8a9tm96153dsger